Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Sep-19 7:17 PM View:  | Harpoon Therapeutics, Inc. (HARP) | 05-Jun-19 | Option Exercise | 169,462 | $0.60 | $101,677.00 | 5649% 3.0K to 172.46K | |
| 16-May-19 8:32 AM View: | Harpoon Therapeutics, Inc. (HARP) | 14-May-19 | Market Purchase | 1,000 | $10.16 | $10,157.30 | 50% 2.0K to 3.0K | 87% |
| 10-May-19 8:31 AM View: | Harpoon Therapeutics, Inc. (HARP) | 08-May-19 | Market Purchase | 1,000 | $10.56 | $10,558.70 | 100% 1.0K to 2.0K | 80% |
| 07-May-19 4:12 PM View: | Harpoon Therapeutics, Inc. (HARP) | 03-May-19 | Market Purchase | 1,000 | $10.53 | $10,530.00 | 100% 0 to 1.0K | 81% |
| 04-Dec-18 7:35 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 03-Dec-18 | Payment of Exercise | 2,824 | $0.30 | $843.25 | (2%) 183.52K to 180.7K | (277%) |
| 02-Nov-18 7:50 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-18 | Payment of Exercise | 2,888 | $0.31 | $908.28 | (2%) 186.41K to 183.52K | (267%) |
| 02-Oct-18 7:32 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Oct-18 | Payment of Exercise | 2,888 | $0.45 | $1,302.49 | (2%) 189.3K to 186.41K | (138%) |
| 05-Sep-18 7:59 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 04-Sep-18 | Payment of Exercise | 2,813 | $0.50 | $1,412.13 | (1%) 192.11K to 189.3K | (111%) |
| 02-Aug-18 7:55 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Aug-18 | Payment of Exercise | 2,813 | $0.47 | $1,308.05 | (1%) 194.92K to 192.11K | (126%) |
| 03-Jul-18 7:43 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 02-Jul-18 | Payment of Exercise | 2,813 | $0.50 | $1,416.63 | (1%) 197.74K to 194.92K | (113%) |
| 04-Jun-18 8:15 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Jun-18 | Payment of Exercise | 2,813 | $0.58 | $1,632.10 | (1%) 200.55K to 197.74K | (83%) |
| 02-May-18 7:16 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-May-18 | Payment of Exercise | 2,813 | $0.74 | $2,081.62 | (1%) 203.36K to 200.55K | (45%) |
| 03-Apr-18 7:52 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 02-Apr-18 | Payment of Exercise | 3,379 | $2.33 | $7,873.07 | (2%) 206.74K to 203.36K | 54% |
| 02-Mar-18 7:49 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Mar-18 | Payment of Exercise | 3,415 | $2.25 | $7,683.75 | (2%) 210.16K to 206.74K | 52% |
| 02-Feb-18 7:35 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Feb-18 | Payment of Exercise | 3,415 | $2.76 | $9,425.40 | (2%) 213.57K to 210.16K | 61% |
| 03-Jan-18 6:59 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 02-Jan-18 | Payment of Exercise | 3,665 | $2.84 | $10,408.60 | (2%) 217.24K to 213.57K | 62% |
| 01-Dec-17 8:27 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Dec-17 | Payment of Exercise | 3,212 | $3.00 | $9,636.00 | (1%) 220.45K to 217.24K | 64% |
| 02-Nov-17 8:23 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-17 | Payment of Exercise | 3,212 | $2.44 | $7,837.28 | (1%) 223.66K to 220.45K | 56% |
| 02-Oct-17 4:09 PM View: | AVANT Immunotherapeutics, I... (CLDX) | 02-Oct-17 | Payment of Exercise | 3,212 | $2.86 | $9,186.32 | (1%) 226.87K to 223.66K | 62% |
| 05-Sep-17 8:17 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Sep-17 | Payment of Exercise | 3,212 | $2.46 | $7,901.52 | (1%) 230.08K to 226.87K | 56% |
| 01-Aug-17 4:30 PM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Aug-17 | Payment of Exercise | 2,869 | $2.29 | $6,570.01 | (1%) 232.95K to 230.08K | 53% |
| 05-Jul-17 4:32 PM View: | AVANT Immunotherapeutics, I... (CLDX) | 03-Jul-17 | Payment of Exercise | 2,869 | $2.47 | $7,086.43 | (1%) 235.82K to 232.95K | 56% |
| 16-Jun-17 9:31 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 15-Jun-17 | Grant | 10,000 | -- | -- | 4% 225.82K to 235.82K | |
| 01-Jun-17 8:09 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Jun-17 | Payment of Exercise | 2,869 | $2.83 | $8,119.27 | (1%) 228.69K to 225.82K | 62% |
| 01-May-17 4:01 PM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-May-17 | Payment of Exercise | 2,869 | $3.33 | $9,553.77 | (1%) 231.56K to 228.69K | 68% |
| 03-Apr-17 4:37 PM View: | AVANT Immunotherapeutics, I... (CLDX) | 03-Apr-17 | Payment of Exercise | 2,869 | $3.61 | $10,357.10 | (1%) 234.43K to 231.56K | 70% |
| 03-Mar-17 9:10 AM View: | AVANT Immunotherapeutics, I... (CLDX) | 01-Mar-17 | Payment of Exercise | 32,927 | $3.54 | $116,562.00 | (12%) 267.36K to 234.43K | 69% |
| 07-Jul-14 8:16 AM View: | Oxigene Inc. (OTLC) | 02-Jul-14 | Grant | 3,847 | -- | -- | 26% 14.76K to 18.61K | |
| 06-Jan-14 4:47 PM View: | Oxigene Inc. (OTLC) | 02-Jan-14 | Grant | 3,584 | -- | -- | 32% 11.18K to 14.76K | |
| 02-Jul-13 4:58 PM View: | Oxigene Inc. (OTLC) | 01-Jul-13 | Grant | 7,407 | -- | -- | 196% 3.77K to 11.18K | |
| 03-Jan-13 5:29 PM View: | Oxigene Inc. (OTLC) | 02-Jan-13 | Grant | 3,773 | -- | -- | 100% 0 to 3.77K | |
| 10-Jun-11 4:49 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 09-Jun-11 | Option Exercise | 54,218 | -- | -- | 277% 19.61K to 73.83K | |
| 31-Dec-08 1:03 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 30-Dec-08 | Market Purchase | 7,500 | $1.29 | $9,707.00 | 62% 12.11K to 19.61K | (98%) |
| 30-Dec-08 3:23 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 29-Dec-08 | Market Purchase | 7,375 | $1.40 | $10,325.00 | 156% 4.73K to 12.11K | (98%) |
| 07-Mar-08 3:42 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 06-Mar-08 | Market Purchase | 3,900 | $3.93 | $15,327.00 | 468% 0.83K to 4.73K | (99%) |
| 26-May-04 9:37 AM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 25-May-04 | Market Purchase | 5,000 | $2.75 | $13,750.00 | 100% 0 to 5.0K | (100%) |